Pasteur Courses

Vaccine Epidemiology

Each theoretical course is followed by practical work sessions for application to concrete situations in vaccination programs. Funding opportunities: If you are a member of the Pasteur Network (see list), consider applying for the Calmette & Yersin Study Grant. The deadline for applying for the scholarship is the same as the deadline for applying for the course.

Practical Information

  • 3 jours / 3 days
  • April 26, 2027 - April 29, 2027
  • Institut Pasteur
  • English

Contacts

VacEpi@pasteur.fr

Registration

  • Deadline : January 15, 2027
  • Attendees : 20

Accreditations:

  • Institut Pasteur Diploma
  • Credits for the Advanced Master degree in Global Health within the Pasteur-Cnam-EHESP School of Public Health

Description

The aim of the course is to supplement knowledge of the various vaccines and vaccinations and to provide an in-depth understanding of the particularities of epidemiological studies in the field of vaccination. Central aspects of the course are indirect protection induced by vaccination and the evaluation of vaccines in an emerging context.
Apart from learners on specific programmes (Specialised Masters and Doctoral Network in Public Health), the target audience is people (professionals or learners) with a Master's-level degree in epidemiology or professional experience related to epidemiology.

Public :

  • Students of the Pasteur-CNAM-EHESP specialised Masters programme
  • PhD students who are members of the doctoral network in public health run by EHESP
  • Continuing education (a Master's degree in epidemiology or professional experience related to epidemiology is required)

Presentation of the course :

This cours targets Mastère, Master and PhD students who wish to consolidate their knowledge and skills in epidemiological methods applied to the control of infectious diseases and clinical prevention. Within this scope, the course focusses on vaccinations against endemic or emerging infectious diseases. 

At the end of the course, students should be able to :

  • Explain different vaccine types and their epidemiological specificities (efficacy, effectiveness against disease/infection/transmission, pharmaco-epidemiology)
  • Explain classic and innovative methods that are used in phases IIII et IV studies of a vaccine life cycle (including clinical trials, observational studies and modeling), discuss biases that are inherent to these designs and propose strategies to mitigated these limites to study validity
  • Explain the different facettes of vaccine-induced indirect protection and its impact at the individual and population level, along with appropriate study designs
  • Propose epidemiological studies that contribute to increase vaccine acceptance, including interventional research

The course requires reading articles in preparation of the sessions.

Download the image

Directors

MUELLER Judith * - EHESP

Members of the course committee

ALMOUSSA Murielle - Institut Pasteur
CHERIET Samia - Institut Pasteur, Paris
FONTANET Arnaud - Institut Pasteur
PONTICELLI Virginie - Institut Pasteur
SALA Monica - Institut Pasteur
WAXIN Hervé - Institut Pasteur

* Representative of Universities